AllianceBernstein
OMIC

AllianceBernstein’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

AllianceBernstein’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-437
Closed -$15.9K – 3273
2023
Q1 		$15.9K Hold
437
– – ﹤0.01% 3136
2022
Q4 		$26.3K Buy
+437
New +$29.3K ﹤0.01% 3208

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein's OMIC Position: Q2 2023 in Review

AllianceBernstein sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 437 shares — an estimated $15.9K sold.

AllianceBernstein first reported a position in OMIC in Q4 2022 and held it in 2 quarters. The position peaked at $26.3K in Q4 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • AllianceBernstein reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • AllianceBernstein sold 437 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $15.9K.
  • AllianceBernstein first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • AllianceBernstein's Singular Genomics Systems, Inc. Common Stock position peaked at $26.3K in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.